USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/12246
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBîrcă, Veronica-
dc.date.accessioned2020-10-20T07:20:31Z-
dc.date.available2020-10-20T07:20:31Z-
dc.date.issued2020-
dc.identifier.citationBÎRCĂ, Veronica. Clinical evolution and treatment of breast cancer in young women. In: MedEspera: the 8th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2020, p. 90-91.en_US
dc.identifier.urihttps://medespera.asr.md/wp-content/uploads/ABSTRACT-BOOK.pdf-
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/12246-
dc.descriptionDepartment of Oncology, Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova, The 8th International Medical Congress for Students and Young Doctors, September 24-26, 2020en_US
dc.description.abstractIntroduction. Breast cancer is the most common cancer diagnosed in women worldwide, with nearly 1.7 million new cases diagnosed annually (25% of the total) and 571,000 deaths. In Europe, breast cancer accounts for the highest share (26.4%) of all cancers in women, with 522,513 new cases, far above colon cancer (11.5%; 228,067 new cases) and lung cancer (8%; 158,196 new cases). The incidence of breast cancer in Moldova in 2018 was 1125, and the morbidity was 360.6 per 100 thousand population. Aim of the study. This study aims to analyze the clinical evolution and treatment of breast cancer at different stages in young women. Materials and methods.. The study is based on a retrospective descriptive analysis carried out for about 3 years. The group included 63 patients, all women between the ages of 24 and 45, diagnosed with breast cancer at various stages. Clinical evolution, stage, tumor size, preoperative treatment and surgical method were evaluated. Results. We found that of 63 patients, 61 had clinical symptoms, while 2 patients were diagnosed during screening. The complaints of the patients included palpation of a hard, immobile, painless tumor of irregular outline – 50 cases (82%); breast swelling – 8 cases (13%); nipple leaks – 2 cases (3%), pain – 1 case (2%). Tumor sizes ranged from 1.0 cm to 5.5 cm. Thirty-eight patients had tumors smaller than 2 cm, 24 patients had tumors with sizes between 2 and 5 cm and 1 patient had tumor of 5.5 cm. There were diagnosed 3 patients (5%) with stage I; 13 patients (21%) with stage IIA; 39 patients (62%) with stage IIB; 4 patients (6%) with stage IIIA; 4 patients (6%) with stage IIIB. Out of 63 patients, 42 patients (67%) received preoperative treatment: chemotherapy – 39 patients (61.9%), radiotherapy – 3 patients (4.7%). Of the patients receiving chemotherapy, 5 patients took 2 courses, 16 patients – 3 courses, 14 patients – 4 courses, 2 patients – 6 courses, 2 patients – 8 courses. Surgical treatment of malignancies was performed by two methods: single mastectomy – 18 malignant tumors (28.5%), Madden radical mastectomy – 45 malignant tumors (71.5%). Conclusions. We found that of 63 patients, 61 had clinical symptoms, while 2 patients were diagnosed during screening. The complaints of the patients included palpation of a hard, immobile, painless tumor of irregular outline – 50 cases (82%); breast swelling – 8 cases (13%); nipple leaks – 2 cases (3%), pain – 1 case (2%). Tumor sizes ranged from 1.0 cm to 5.5 cm. Thirty-eight patients had tumors smaller than 2 cm, 24 patients had tumors with sizes between 2 and 5 cm and 1 patient had tumor of 5.5 cm. There were diagnosed 3 patients (5%) with stage I; 13 patients (21%) with stage IIA; 39 patients (62%) with stage IIB; 4 patients (6%) with stage IIIA; 4 patients (6%) with stage IIIB. Out of 63 patients, 42 patients (67%) received preoperative treatment: chemotherapy – 39 patients (61.9%), radiotherapy – 3 patients (4.7%). Of the patients receiving chemotherapy, 5 patients took 2 courses, 16 patients – 3 courses, 14 patients – 4 courses, 2 patients – 6 courses, 2 patients – 8 courses. Surgical treatment of malignancies was performed by two methods: single mastectomy – 18 malignant tumors (28.5%), Madden radical mastectomy – 45 malignant tumors (71.5%).en_US
dc.language.isoenen_US
dc.publisherMedEsperaen_US
dc.subjectbreast canceren_US
dc.subjectevolutionen_US
dc.subjecttreatmenten_US
dc.titleClinical evolution and treatment of breast cancer in young womenen_US
dc.typeArticleen_US
Appears in Collections:MedEspera 2020

Files in This Item:
File Description SizeFormat 
CLINICAL_EVOLUTION_AND_TREATMENT_OF_BREAST_CANCER_IN.pdf444.52 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback